Additionally, some studies have found evidence that GLP-1–based therapies alleviate pathology associated with other diseases such as dementia in non-diabetic individuals, although there is controversy about the potential for these therapies in dementia treatment based on different findings, especially in human studies12,74. Here, GLP1R is linked to dementia.